Cargando…
P1423: GENOTYPE GUIDED DISEASE MANAGEMENT IN HBSC SICKLE CELL DISEASE USING PHLEBOTOMY: IMPACT ON SYMPTOMS AND DISEASE PARAMETERS
Autores principales: | Asemissen, Anne-Marie, von Feldmann, Feline, Dickerhoff, Roswitha, Güsmer, Corinna, Bokemeyer, Carsten, Mährle, Thorben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430440/ http://dx.doi.org/10.1097/01.HS9.0000972580.80926.24 |
Ejemplares similares
-
Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)
por: da Guarda, Caroline Conceição, et al.
Publicado: (2020) -
Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype
por: Lim, Wei S., et al.
Publicado: (2018) -
Cation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype)
por: Hannemann, A., et al.
Publicado: (2015) -
PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS
por: Jebali, Amna, et al.
Publicado: (2023) -
Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)
por: Brewin, John N., et al.
Publicado: (2020)